Takeda Moves Quickly to Sell Dollar Bonds for Shire Plc Deal
- Japanese firm follows 7.5 billion-euro deal with dollar sale
- Takeda already raised more than $20 billion to replace loan
This article is for subscribers only.
Takeda Pharmaceutical Co.’s dollar bond may be the last piece in the company’s plan to replace a $31 billion loan used to fund its acquisition of Shire Plc. That $62 billion deal has pushed the Japanese firm’s finances, and its credit rating, and the company has moved quickly to tackle the loan, which has 364-day maturity.